vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	44	30	69	90	137	102
Market Cap Growth	-16.16%	-56.62%	-22.63%	-34.81%	34.94%	-5.69%
Enterprise Value	-7	21	46	77	133	107
PE Ratio	-	-1.48	-3.62	-6.90	-16.17	-5.68
PS Ratio	44.47	-	34.35	22.37	21.43	36.84
PB Ratio	2.14	-1.22	-6.45	-9.20	-1.72	-2.08
P/FCF Ratio	-3.33	-1.58	-4.32	-4.64	-7.63	-4.47
P/OCF Ratio	-3.33	-1.58	-4.33	-4.64	-7.63	-4.42
EV/Sales Ratio	18.87	-	22.63	19.25	20.67	38.77
EV/EBITDA Ratio	-0.92	-1.05	-2.42	-6.04	-17.19	-9.67
EV/EBIT Ratio	-0.92	-1.05	-2.41	-6.00	-16.98	-9.64
EV/FCF Ratio	-0.89	-1.11	-2.85	-3.99	-7.37	-4.71
Debt / Equity Ratio	0.01	-0.02	-0.07	-0.10	-0.01	-0.15
Debt / EBITDA Ratio	-0.01	-0.03	-0.04	-0.07	-0.12	-0.64
Debt / FCF Ratio	-0.01	-0.03	-0.04	-0.05	-0.05	-0.31
Quick Ratio	5.97	0.90	3.18	1.59	0.92	0.13
Current Ratio	6.04	1.00	3.52	1.84	1.13	0.21
Asset Turnover	0.04	0	0.06	0.17	0.64	0.29
Interest Coverage	-1577.15	-1556.69	-1263.27	-1071.67	-11.28	-6.08
Return on Equity (ROE)	151.60%	85.80%	174.50%	38.40%	12.90%	35.20%
Return on Assets (ROA)	-80.40%	-104.90%	-60.90%	-54.50%	-85.30%	-187.60%
Return on Capital (ROIC)	-108.51%	103.22%	215.42%	227.67%	15.31%	47.88%
Earnings Yield	-46.36%	-67.35%	-27.65%	-14.50%	-6.18%	-17.59%
FCF Yield	-47.78%	-63.46%	-23.15%	-21.55%	-13.10%	-22.37%
Buyback Yield / Dilution	-15.14%	-	-16.15%	-21.87%	-23.33%	-47.01%
Total Shareholder Return	-15.14%	-	-16.15%	-21.87%	-23.33%	-47.01%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).